A genetic component in some women breaks down contraceptive hormones

Women who get pregnant while using birth control may carry a gene that breaks down the hormones common in contraceptives, according to researchers at the University of Colorado Anschutz Medical Campus.

"The findings mark the first time a genetic variant has been associated with ," said the study's lead author Aaron Lazorwitz, MD, assistant professor of Obstetrics and Gynecology at the University of Colorado School of Medicine.

The study was published today in the journal Obstetrics & Gynecology.

Contraceptives are not 100 percent effective but the reasons they fail have never been fully explained.

Women are usually blamed for not using the medication properly. But Lazorwitz and his colleagues suspected that there may be other reasons at work. They looked at 350 healthy with a median age of 22.5 years old and a contraceptive implant in place for between 12 and 36 months.

The researchers found that 5 percent of women tested had a gene called CYP3A7*1C that is usually active in fetuses and then switched off before birth. But some women with this gene continue to make the CYP3A7 enzyme into adulthood.

"That enzyme breaks down the hormones in birth control and may put women at a higher risk of pregnancy while using contraceptives, especially lower dose methods," Lazorwitz said.

The variant could be found during genetic screening.

"When a woman says she got pregnant while on birth control the assumption was always that it was somehow her fault," Lazorwitz said. "But these findings show that we should listen to our patients and consider if there is something in their genes that caused this."

The findings point to how pharmacogenomics, a relatively new field which analyzes how genes affect a person's response to drugs, has the potential to dramatically alter the field of women's health.

"Especially in light of the social, financial, and emotional consequences of contraceptive failure and the breadth of indications for throughout a woman's life-span," the study said.

Lazorwitz said the study may help spur the development of more precise medical tools that can help tailor treatment to individual patients.

"As more becomes available, clinicians may need to consider adding to increased steroid hormone metabolism in their differential diagnosis for in women reporting perfect adherence to hormonal contraceptive methods," he said.


Explore further

Oral contraceptive use not associated with increased birth defects risk

More information: Influence of Genetic Variants on Steady-State Etonogestrel Concentrations Among Contraceptive Implant Users Obstetrics & Gynecology. DOI: 10.1097/AOG.0000000000003189
Journal information: Obstetrics & Gynecology

Citation: A genetic component in some women breaks down contraceptive hormones (2019, March 14) retrieved 19 August 2019 from https://medicalxpress.com/news/2019-03-genetic-component-women-contraceptive-hormones.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
 shares

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more